Regulation of cardiac fibroblast collagen synthesis by adenosine: Roles for Epac and PI3K

American Journal of Physiology - Cell Physiology

Volumn 296, Issue 5, 2009, Pages

  Villarreal, Francisco ^a,c   Epperson, Sara A ^b   Ramirez Sanchez, Israel ^a   Yamazaki, Katrina G ^a   Brunton, Laurence L ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

A2 receptors; Cardiac collagen deposition; Epac; Phosphoinositol 3 kinase

Indexed keywords

ADENOSINE; ADENOSINE 2 RECEPTOR; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; ANGIOTENSIN II; ANTIPORTER; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE FACTOR DIRECTLY ACTIVATED BY CYCLIC AMP; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; FIBROBLAST; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; COLLAGEN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FIBROBLASTS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

RATTUS;

EID: 66149087240     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00291.2008     Document Type: Article

References (31)

1. Bradley J, Reisert J, Frings S. Regulation of cyclic nucleotide-gated channels. Curr Opin Neurobiol 15: 343-349, 2005.
2. Brilla CG, Rupp H, Funck R, Maisch B. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 16, Suppl O: 107-109, 1995.
3. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45: 657-687, 2005.
4. Carling D, Clarke PR, Zammit VA, Hardie DG. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem 186: 129-136, 1989.
5. Carroll EP, Janicki JS, Pick R, Weber KT. Myocardial stiffness and reparative fibrosis following coronary embolisation in the rat. Cardiovasc Res 23: 655-661, 1989.
6. Chen Y, Epperson S, Makhsudova L, Ito B, Suarez J, Dillmann W, Villarreal F. Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 287: H2478-H2486, 2004.
7. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477, 1998.
8. Dubey RK, Gillespie DG, Jackson EK. Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors. Hypertension 31: 943-948, 1998.
9. Dubey RK, Gillespie DG, Mi Z, Jackson EK. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors. Circulation 96: 2656-2666, 1997.
10. Dubey RK, Gillespie DG, Zacharia LC, Mi Z, Jackson EK. A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension 37: 716-721, 2001.
11. 10a.Epperson SA, Brunton LL, Ramirez-Sanchez I, Villarreal F. Adenosine receptors and second messanger signaling pathways in rat cardiac fibroblasts. Am J Physiol Cell Physiol (February 25, 2009). doi:10.1152/ajpcell.00290.2008.
12. Factor SM, Robinson TF. Comparative connective tissue structure-function relationships in biologic pumps. Lab Invest 58: 150-156, 1988.
13. Gustafsson AB, Brunton LL. Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1beta and NO: role of cGMP-stimulated PDE2. Am J Physiol Cell Physiol 283: C463-C471, 2002.
14. Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120, 2003.
15. Jalil JE, Doering CW, Janicki JS, Pick R, Clark WA, Abrahams C, Weber Structural vs KT. Contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle. J Mol Cell Cardiol 20: 1179-1187, 1988.
16. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64: 1041-1050, 1989.
17. Jensen J, Brennesvik EO, Lai YC, Shepherd PR. GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3. Cell Signal 19: 204-210, 2007.
18. Kaupp UB, Seifert R. Cyclic nucleotide-gated ion channels. Physiol Rev 82: 769-824, 2002.
19. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, Gupta A, Adams JJ, Katsis F, van Denderen B, Jennings IG, Iseli T, Michell BJ, Witters LA. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162-168, 2003.
20. Liu X, Ostrom RS, Insel PA. cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am J Physiol Cell Physiol 286: C1089-C1099, 2004.
21. Olson ER, Shamhart PE, Naugle JE, Meszaros JG. Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase C delta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension 51: 704-711, 2008.
22. Racke K, Haag S, Bahulayan A, Warnken M. Pulmonary fibroblasts, an emerging target for anti-obstructive drugs. Naunyn Schmiedebergs Arch Pharmacol 378: 193-201, 2008.
23. Robinson TF, Cohen-Gould L, Factor SM, Eghbali M, Blumenfeld OO. Structure and function of connective tissue in cardiac muscle: collagen types I and III in endomysial struts and pericellular fibers. Scanning Microsc 2: 1005-1015, 1988.
24. Schulte G, Fredholm BB. The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp Cell Res 290: 168-176, 2003.
25. Villarreal F, Zimmermann S, Makhsudova L, Montag AC, Erion MD, Bullough DA, Ito BR. Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects. Mol Cell Biochem 251: 17-26, 2003.
26. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861, 1993.
27. Wang L, Liu F, Adamo ML. Cyclic AMP inhibits extracellular signalregulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1. J Biol Chem 276: 37242-37249, 2001.
28. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 96: 4065-4082, 1997.
29. Yin F, Wang YY, Du JH, Li C, Lu ZZ, Han C, Zhang YY. Noncanonical cAMP pathway and p38 MAPK mediate beta 2-adrenergic receptor- induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol 40: 384-393, 2006.
30. Yokoyama U, Patel HH, Lai NC, Aroonsakool N, Roth DM, Insel PA. The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci USA 105: 6386-6391, 2008.
31. Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KT. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 154: 171-178, 1996.